细胞外囊微RNA介导的转录调节可能会导致患有莱维体分子病理的痴呆症
Fatma Busra Isik1, Helen Miranda Knight1, Anto P Rajkumar2,3
1School of Life Science, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
Acta neuropsychiatrica
|June 20, 2023
概括
患有勒维体痴呆症 (DLB) 的小细胞外囊 (SEV) 可能调节参与神经元发育和神经精神疾病的基因. 这些发现为DLB提供了潜在的治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 勒维体痴呆症 (DLB) 是第二常见的痴呆症,其特征是α-synucleinopathy.
- 在DLB患者中,小细胞外囊泡 (SEV) 传递α-synuclein oligomerization,并与死后大脑共享miRNA签名.
- 这些miRNA标记在DLB病变发生过程中的功能意义尚不清楚.
研究的目的:
- 为了确定从DLB患者的血清SEV中差异表达miRNA的潜在标.
- 分析这些miRNA目标的功能影响.
- 探索蛋白质相互作用和相关途径.
主要方法:
- 利用miRBase和miRDB数据库识别了在DLB血清SEV中发现的六种特定miRNA (MIR26A1,MIR320C2,MIR320D2,MIR548BA,MIR556,MIR4722) 的目标.
- 使用EnrichR进行基因组丰富分析以确定功能影响.
- 应用Reactome路径分析来研究蛋白质-蛋白质相互作用.
主要成果:
- 鉴定了4278个由这些SEV miRNAs调节的基因,在与神经元发育,细胞通信,囊泡传输,细胞亡,细胞循环,蛋白质修饰和自相关的途径中显著丰富.
- 发现了miRNA标基因和神经精神疾病之间的显著关联.
- 在信号传导,转录调节和细胞因子信号传导途径中发现了丰富.
结论:
- 提供了通过转录调节将DLB相关的SEV小RNA点与Lewy病理联系起来的in-silico证据.
- 强调需要对已识别的功能障碍途径进行实验验证.
- 基于这些发现,针对DLB的新型治疗策略的潜在建议.
更多相关视频
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
720
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.7K
相关概念视频
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
